Table 4 PAF and direct costs (NIS) attributable to overweight and obesity by diagnoses - Israeli adults (2016)
From: Mortality, hospital days and treatment costs of current and reduced sugar consumption in Israel
| Â | PAF overweight | PAF obesity | Total cost | Attributable to overweight & obesity | Â |
|---|---|---|---|---|---|
Coronary artery disease | 16.1% | 28.5% | 1,055,915,767 | 470,784,150 | 21.5% |
Diabetes type II | 33.5% | 56.5% | 511,313,763 | 460,182,387 | 21.1% |
Hypertension | 16.8% | 30.4% | 943,186,656 | 445,157,136 | 20.4% |
Congestive heart failure | 12.1% | 24.0% | 462,954,791 | 166,984,682 | 7.6% |
Osteoarthritis | 31.1% | 35.8% | 247,895,278 | 165,852,084 | 7.6% |
Stroke | 8.2% | 16.3% | 490,337,015 | 119,962,933 | 5.5% |
Colorectal cancer | 18.0% | 23.8% | 220,788,825 | 92,322,002 | 4.2% |
Pulmonary embolism | 28.2% | 48.6% | 93,633,779 | 71,915,718 | 3.3% |
Asthma | 8.4% | 19.1% | 260,546,602 | 71,698,574 | 3.3% |
Gallbladder disease | 9.4% | 23.7% | 115,622,301 | 38,181,949 | 1.7% |
Kidney cancer | 19.1% | 28.5% | 46,068,752 | 21,944,698 | 1.0% |
Pancreatic cancer | 10.6% | 26.1% | 52,536,885 | 19,257,766 | 0.9% |
Endometrial cancer | 16.3% | 44.2% | 28,576,252 | 17,298,101 | 0.8% |
Breast cancer | 2.8% | 4.3% | 124,719,472 | 8,786,692 | 0.4% |
Prostate cancer | 6.9% | 2.0% | 49,259,925 | 4,358,259 | 0.2% |
Ovarian cancer | 6.0% | 8.8% | 28,750,951 | 4,263,974 | 0.2% |
Esophageal cancer | 5.7% | 7.0% | 23,724,293 | 3,015,682 | 0.1% |
Non-alcoholic fatty liver | 14.6% | 22.4% | 4,413,971 | 1,633,711 | 0.1% |
Gout | 31.4% | 16.1% | 3,409,277 | 1,618,618 | 0.1% |
Total | Â | Â | 6,512,219,714 | 2,185,219,115 | 100.0% |